Romuald Corbau
individual
About
Romuald Corbau, Ph.D., is a gene therapy scientist and biotech executive currently serving as Chief Scientific Officer at Capsida Biotherapeutics. Earlier roles include CSO positions at Adverum Biotechnologies, GenEdit (now BreezeBio), and Freeline Therapeutics, plus translational research leadership at Spark Therapeutics with a concurrent appointment at the Children's Hospital of Philadelphia. His career has focused on AAV-based gene therapy, ocular and CNS programs, rare diseases, and translational drug discovery.
Areas of interest
gene therapygenetic medicinesAAV vectorsocular therapeuticsCNS therapeuticsrare diseasedrug discoverytranslational researchbiotech